Innovative Medicines Initiative

About IMI

The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safe medicines for patients.IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA. Read more

Ebola+ Programme

IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. The Ebola+ programme exemplifies how such multi-faceted collaborative efforts can have a stronger impact than any single player could alone. IMI2 offers a unique opportunity to complement the ongoing European and international efforts against Ebola.

Read more

From Twitter

RT @Cwrit42W: Fantastic poster and thrilled that @IMI_EPAD chosen to be on timeline @IMI_JU @AlzheimerEurope https://t.co/IbA3O1CWjD about 11 hours ago by EFPIA
RT @kuiper_em: Podcast - Brexit, Article 50 and beyond (E!Sharp Conversations) @EFPIA https://t.co/fQF7tmIwnd 1 day ago by EFPIA